The Ache Continues For Bedraggled Pharma Heavyweight Pfizer
Any other analyst reduce expectancies for Pfizer (PFE) on Friday after the pharma heavyweight issued a disappointing 2024 outlook early this week. Pfizer inventory is now buying and selling at its lowest